Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jan 22, 2010

NEW YORK (GenomeWeb News) - Vance Vanier will take over the president and CEO positions at Navigenics. Vanier started at Navigenics in 2008 and was serving as chief medical officer of the consumer genomics firm. Before joining Navigenics, he was a partner at Mohr Davidow Ventures. He also is a clinical faculty member at Stanford University Medical Center.

SQI Diagnostics has named Yehuda Shoenfeld to be chairman of its scientific advisory board. Shoenfeld is head of the Department of Medicine ‘B’ and the Center for Autoimmune Diseases at Sheba Medical Center, and he is chair for Research of Autoimmune Diseases at Tel-Aviv University, Israel.

The Automation Partnership has appointed Phillip Sefton to be its commercial director. Phillips formerly was involved in sales and marketing for life sciences and diagnostics firms, including a 12-year stint as VP of commercial operations at Qiagen.

Complete Genomics recently disclosed that Aaron Solomon joined the firm as vice president of business development and Mauro Folena joined as vice president of operations last year.

Most recently, Solomon was vice president of business development at Tethys Biosciences. Prior to that, he held positions in sales, marketing, and business development at Incyte, ParAllele, and Affymetrix. He graduated from the University of California, Irvine, with a BS in biological sciences

Mauro Folena most recently led advanced manufacturing at Proteus Biomedical. Before that, he was director of operations at Coherent, vice president of operations at Aerogen, and held positions at Honeywell International and National Semiconductor. Folena holds a BS in information systems management from the University of San Francisco.

The Coriell Personalized Medicine Collaborative has formed a new Pharmacogenomics Advisory Group headed by Issam Zineh, associate director for genomics at the Office of Clinical Pharmacology in the US Food and Drug Administration's Center for Drug Evaluation and Research.

Other members of the PGx advisory group include Amalia Issa, director of the Personalized Medicine and Targeted Therapeutics program at the Abramson Center for the Future of Health;
 Andy Godwin, director of the Clinical Molecular Genetics Laboratory at the Fox Chase Cancer Center;
 Cal Knowlton, CEO of excelleRx and a member of the board of the American Pharmacists Association Foundation;
 Howard McLeod, Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy at the University of North Carolina's School of Pharmacy and head of the Pharmacogenetics for Every Nation Initiative;
 Michael Ezekowitz, professor of cardiology at the Lankenau Institute for Medical Research;
 Michael Murray, director of the General Genetics Clinic at Brigham and Women's Hospital; Steve Murphy, founder of Helix Health;
 Teri Klein, senior research scientist in genetics at Stanford University; and
 Wolfgang Sadee, chair of the Department of Pharmacology at Ohio State University.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.